Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.

This study is recruiting. It focuses on bipolarity and currently lists participation information in Canada.
Leave your email and HopeStage can help you better understand this study.
This observational study is following people with Depression in bipolarity, bipolarity, Treatment- Resistant bipolarity, or Type 2 bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.
The official record suggests in-person participation through a university, with sites including University Health Network in Toronto and Centre for Addiction and Mental Health in Toronto. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually matching the main diagnosis and being able to understand the study and consent. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it adds public evidence around bipolarity. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
Taking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in Canada.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Centre for Addiction and Mental Health, a hospital or academic medical center. The Centre for Addiction and Mental Health is a mental health hospital and research center. The sponsor is based in Canada. Sponsor website: https://www.camh.ca. You can verify the sponsor and study responsibility in the official registry record.
This study may involve medication or study treatment, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me